Development of antiviral therapeutics combating coxsackievirus type B3 infection
Enteroviruses comprise highly diverse group of single-stranded positive RNA viruses belonging to Enterovirus genus, Picornaviridae family. They are the most prevalent viruses worldwide highlighted by high resistance to environmental cues. Enteroviruses normally cause seasonal self-limiting infection...
Main Authors: | A. S. Volobueva, V. V. Zarubaev, K. S. Lantseva |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Sankt-Peterburg : NIIÈM imeni Pastera
2021-02-01
|
Series: | Infekciâ i Immunitet |
Subjects: | |
Online Access: | https://www.iimmun.ru/iimm/article/view/1273 |
Similar Items
-
Pharmacological and Biological Antiviral Therapeutics for Cardiac Coxsackievirus Infections
by: Jens Kurreck, et al.
Published: (2011-10-01) -
The Evolution of Pleconaril: Modified <i>O</i>-Alkyl Linker Analogs Have Biological Activity towards Coxsackievirus B3 Nancy
by: Alexandrina Volobueva, et al.
Published: (2020-03-01) -
Oral administration of interferon-α2b-transformed <it>Bifidobacterium longum </it>protects BALB/c mice against coxsackievirus B3-induced myocarditis
by: Yu Zhijian, et al.
Published: (2011-12-01) -
Coxsackieviruses B1–6 as Etiological Factor of Enterovirus Infection
by: N. I. Romanenkova, et al.
Published: (2016-07-01) -
Inhibition of RNA Helicase Activity Prevents Coxsackievirus B3-Induced Myocarditis in Human iPS Cardiomyocytes
by: Soo-Hyeon Yun, et al.
Published: (2020-04-01)